MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced or Metastatic Breast Cancer
Interventions: DRUG: MEN1611|DRUG: Trastuzumab|DRUG: Fulvestrant
Sponsor: Menarini Group